sarcoma section

Sarcoma News & Features

Prognostic factors of pazopanib in advanced soft tissue sarcomas

A new analysis confirmed the importance of known prognostic factors such as performance status and tumor grading for having a long-term outcome in patients treated with pazopanib for metastatic soft tissue sarcoma. In addition, hemoglobin at baseline was found to be a new prognostic factor.

Potential therapeutic target identified for incurable, rare type of soft-tissue cancer

A deadly, rare type of soft-tissue cancer may be completely eradicated simply by inhibiting a key protein involved in its growth, according to a new research report.

Carbon ion radiotherapy works for inoperable spinal sarcomas

Carbon ion radiotherapy (CIRT) appears to be safe and effective for the treatment of persons with unresectable spinal sarcoma, researchers have affirmed.

Sarcoma drug duo more effective than one or the other

Combining a Wee1 protein inhibitor with the chemotherapy agent gemcitabine reduced sarcoma tumor volume more than did either drug alone.

Expression, genomic patterns predict sarcoma progression

Expression, genomic patterns predict sarcoma progression

In synovial sarcoma, metastasis development is linked to chromosome complexity.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs